Blocking Cancer-Nerve Crosstalk for Treatment of Metastatic Bone Cancer Pain.
Xu ChuHongjun ZhuangYanyan LiuJinjin LiYa WangYaqin JiangHuilin ZhangPeiran ZhaoYang ChenXingwu JiangYelin WuWen-Bo BuPublished in: Advanced materials (Deerfield Beach, Fla.) (2022)
The tumor microenvironment is a complex milieu where neurons constitute an important non-neoplastic cell type. From "cancer neuroscience," the crosstalk between tumors and neurons favors the rapid growth of both, making the cancer-nerve interaction a reciprocally beneficial process. Thus, cancer-nerve crosstalk may provide new targets for therapeutic intervention against cancer and cancer-related symptoms. We proposed a nerve-cancer crosstalk blocking strategy for metastatic bone cancer pain treatment, achieved by Mg/Al layered-double-hydroxide nanoshells (Mg/Al-LDH) with AZ-23 loaded inside and alendronate decorated outside. The pain-causing H + is rapidly eliminated by the LDH, with neurogenesis inhibited by the antagonist AZ-23. As positive feedback, the decreased pain reverses the nerve-to-cancer Ca 2+ crosstalk-related cell cycle, dramatically inhibiting tumor growth. All experiments confirm the improved pain threshold and enhanced tumor inhibition. The study may inspire multidisciplinary researchers to focus on cancer-nerve crosstalk for treating cancer and accompanied neuropathic diseases.
Keyphrases
- papillary thyroid
- squamous cell
- chronic pain
- cell cycle
- randomized controlled trial
- lymph node metastasis
- small cell lung cancer
- squamous cell carcinoma
- pain management
- drug delivery
- cell proliferation
- neuropathic pain
- depressive symptoms
- highly efficient
- smoking cessation
- postmenopausal women
- gold nanoparticles
- quantum dots
- sleep quality
- bone regeneration